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ABSTRACT 
Synthetic drugs such as piperazines are among the most commonly abused drugs 
and are typically consumed by younger populations. Because of their popularity, 
developing optimized analytical strategies designed to improve detection and 
interpretation of synthetic piperazines is of interest to the forensic community. To 
improve the likelihood that a substance of interest is detected, careful evaluation into the 
mass spectrometry signal is required. However, with all analytical pursuits, there is a 
limit at which the substance cannot be detected with certainty; thus a threshold is 
commonly referred to as the limit of detection (LOD). Formally, the LOD is the 
minimum amount of analyte (concentration, mass, number of molecules, etc.) that can be 
detected at a known confidence level. 
The purpose of this research was to use common analytical methods to calculate 
the LOD and verify the results with previous work at the Boston University forensic 
toxicology laboratory. Data from the Liquid Chromatography-tandem Mass Spectrometer 
(LC-MS/MS) was previously generated and consisted of signal intensity information in 
the form of peak height and peak area, from titrations of eight synthetic piperazines that 
included:  Benzylpiperazine (BZP), 1-(3-chlorophenyl)-piperazine (mCPP), 3-
trifluoromethylphenylpiperazine monohydrochloride (TFMPP), methylbenzylpiperazine 
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(MBZP), 1-(4-fluorobenzyl)-piperazine (FBZP), 2,3-dichlorophenylpiperazine (DCPP), 
para-fluorophenylpiperazine (pFPP) and para-methoxyphenylpiperazine (MeOPP).  
Generally, the LOD is determined by first evaluating the signal in the absence of analyte 
and determining the probability that signal, ?̂?, crosses the signal threshold, 𝑆𝑇. The signal 
threshold is based upon the false detection rate the laboratory can withstand for a given 
interpretation scheme. In instances where very small levels of false detections can be 
tolerated, a large 𝑆𝑇 is chosen. In other circumstances, where noise detection can 
adequately be interpreted, a low 𝑆𝑇 is chosen. In chromatography and radiography the 
typical one sided =0.003. 
The number of molecules for each analyte at each concentration (20 ng/mL, 50 
ng/mL, 200 ng/mL, 500 ng/mL, 1000 ng/mL and 2000 ng/mL) was determined and used 
throughout this work. Peak area signals and ratios versus number of molecules for each 
analyte were used to, first, visually inspect the linearity of signal to analyte level. It was 
determined that using internal standards improved linearity, as expected; however, the 
data suggested that absolute signal intensity was sufficient to compute the LOD for these 
compounds. Generally accepted methods of calculating LOD were not used for this 
research as the signal from the blank was not detected most likely due to the sensitivity of 
the instrument used. This study used an extrapolation of the data and propagation of 
errors method to calculate the LOD as the signal from the blank was not needed. For all 
eight analytes, the LOD calculated was similar to the lowest concentration (20 ng/mL) 
used when validating this method.  
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This research needs to be expanded on to include more concentration points and 
see the plateau effect at higher concentrations. This will provide information to analytical 
chemists when a blank signal is not available about how the LOD can be calculated with 
high confidence. 
viii 
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1. INTRODUCTION 
1.1 Background 
Novel Psychoactive Substances (NPS) are heterogeneous groups of psychoactive 
substances that are obtained through the modification of a chemical structure of an 
already existing product or drug [1], and are ubiquitous [2].  
Synthetic piperazines are designer drugs that are synthetic analogs of controlled 
substances that have slight modifications to their structure and are intended to mimic the 
pharmacological effects of known drugs of abuse [3, 4]. Piperazines and their derivatives 
are six-membered rings with oppositely positioned nitrogen atoms. Piperazine derivatives 
are divided into two classes, benzylpiperazines and phenylpiperazines [3]. This research 
will focus on the benzylpiperazines (BZP) and its derivatives including 1-(3-
chlorophenyl) piperazines (mCPP), 3-trifluoromethylphenylpiperazine 
monohydrochloride (TFMPP), methylbenzylpiperazine (MBZP), 1-(4-fluorobenzyl)-
piperazine (FBZP), 2,3-dichlorophenylpiperazine (DCPP), para-fluorophenylpiperazine 
(pFPP) and para-methoxyphenylpiperazine (MeOPP).  Structures of these compounds are 
displayed in Figure 1. These piperazines derivatives are very similar in structure and have 
similar mechanisms of action. 
 Hondebrink and colleagues demonstrate a novel mode of action of piperazines 
derivatives and how the inhibition of human gamma-aminobutyric acid (GABA) 
receptors is structure-dependent [4]. Using Xenopus laevis oocytes, they studied how the 
different drugs (BZP, mCPP, TFMPP) affected the ion current on injected 
complementary deoxyribonucleic acid (DNA) as it related to the inhibition of GABA 
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receptors. They showed that the piperazine derivatives significantly inhibited the ion 
current with different potencies. These results implied that piperazine derivatives act as 
competitive antagonists at the GABA-binding site. Because of this result, they concluded 
that it is difficult to predict the potency of new piperazine derivatives as it depends on 
their structure, functional groups and the position of these groups relative to one another 
[4]. This finding is significant because it suggests that different piperazines will have 
similar effects on the body, but determining the potency of new derivatives may not be as 
facile. Therefore, it may be difficult to infer if a substance was used at a recreational dose 
or if it was ingested for ulterior purposes. 
 
Benzylpiperazine 
(BZP)  meta-Chlorophenylpiperazine 
(mCPP) 
 
Trifluoromethylphenylpiperazine 
(TFMPP) 
 
para-Fluorophenylpiperazine 
(pFPP) 
 
para-Methoxyphenylpiperazine 
(MeOPP) 
 
2,3-Dichlorophenylpiperazine 
(DCPP) 
 
Methylbenzylpiperazine 
(MBZP) 
 
1-(4-fluorobenzyl)-piperazine 
(FBZP) 
Figure 1. Chemical Structures. BZP, mCPP, TFMPP, pFPP, MeOPP, DCPP, MBZP and FBZP [5] 
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1.1.1 BZP 
Benzylpiperazine (BZP) was the first piperazine derived drug in the US.  BZP is a 
stimulant that gained popularity in the early 2000s and was a legal alternative to 
amphetamine and its derivatives [6, 7].  BZP is used to elevate the synaptic dopamine and 
serotonin levels producing hallucinatory effects [3]. BZP was synthesized and was tested 
as an anti-helminthic agent for the treatment of intestinal roundworm infections [3]. In 
1970, BZP was also investigated as an antidepressant but was not pursued due to its 
abuse potential [3, 8]. New Zealand legally marketed BZP in 1999 as a party drug as 
youth seeked it for its stimulatory effects [3, 9]. Over the next several years, BZP 
increased in popularity due to its lack of regulation. It became more abused by students to 
increase alertness, by young women for its anorectic properties and by the horse racing 
industry as a performance enhancer among many others [3]. In 2004, BZP was 
permanently placed among the schedule I drugs in the US by the Drug Enforcement 
Agency (DEA) [3]. 
1.1.2 mCPP  
The use of 1-(3-chlorophenyl)-piperazine (mCPP) was first reported in Sweden 
and in the Netherlands [1]. mCPP is a serotonin receptor agonist that has been studied to 
treat migraines but often induces severe hallucinations, panic attacks and nausea [1, 10, 
11]. mCPP is an active metabolite of therapeutic drugs used for antidepressants and mild 
tranquilizers but has been reported to induce anxiety, agitation, drowsiness, visual 
hallucinations and tachycardia [1]. 
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1.1.3 TFMPP 
 While BZP is the most studied piperazine, it has been reported that BZP and 
TFMPP are commonly combined in order to mimic the use of 3,4-
Methylenedioxymethamphetamine (MDMA) in humans [1, 8, 9]. It was determined that 
TFMPP is more extensively metabolized than BZP as the ratio of brain-to-blood 
concentration of TFMPP was in excess of one order magnitude demonstrating extremely 
high tissue concentrations in previous work [3]. Baumann et al demonstrated that, in 
combination, TFMPP and BZP mimic the effects of MDMA. They showed that BZP, 
TFMPP and MDMA all increased the serotonin levels in rats and the combination of 
BZP/TFMPP showed a similar effect [12]. TFMPP blocks serotonin reuptake from the 
synaptic cleft causing the similar effects of MDMA [3]. Because of the potency of the 
combination of TFMPP and BZP, and its effects on the brain and body, specifically with 
its effect on synaptic levels of dopamine, serotonin and norepinephrine, Katz and 
colleagues have termed BZP a “messy drug” [3]. TFMPP and BZP ionize in different 
ways and thus the two compounds can analytically be resolved by mass spectrometry. 
Specifically, BZP has a parent ion with a mass-to-charge (m/z) ratio of 91 whereas 
TFMPP has its parent ion m/z ratio at 188 [13, 14]. 
1.1.4 pFPP 
 para-fluorophenylpiperazine (pFPP) is a possible metabolite of Niaprazine, which 
has been studied in rats to decrease norepinephrine and dopamine levels in the brain and 
as a hypnotic antihistamine in the 1980s [15]. It was rediscovered more recently in 2003 
as a potential recreational drug and sold as a “party pill” in New Zealand. It has been 
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used in the black market “ecstacy” pills around the world [16]. In 2008, New Zealand 
added it to the list of illegal drugs as it also became a drug detected in drug facilitated 
sexual assaults [16].  
1.1.5 MeOPP 
 Like TFMPP, para-methoxyphenylpiperazine (MeOPP) has been shown to exert a 
major part of their mechanism of action as a nonselective serotonin receptor agonist and 
to cause feelings of euphoria and energy [17]. MeOPP also shares many mechanisms of 
action with amphetamines, however, at a less potent level. Because of this MeOPP was 
originally thought to have a very low abuse potential [18]. Like pFPP, MeOPP was 
scheduled as a Class C drug in New Zealand but remains unscheduled in the US at the 
federal level, however it is a Schedule I controlled substance in Florida and is illegal to 
buy, sell or possess there [18].  
1.1.6 DCPP 
 A close analog to mCPP, 2,3-dichlorophenylpiperazine (DCPP) a precursor to the 
synthesis of aripiprazole, which is a drug used to treat severe mental disorders like 
schizophrenia [19]. While it is not on the controlled substances list in the US, it is illegal 
in Japan and Hungary when it was identified as a designer drug in seized samples [19]. 
1.1.7 MBZP 
 A derivative of BZP, methylbenzylpiperazine (MBZP) is a stimulant and has been 
sold initially in New Zealand as an ingredient in legal recreational drugs known as “party 
pills” and is now found in countries across the world [20]. It has slightly weaker effects 
than BZP and less negative side effects, however, it was also placed on the Class C 
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schedule list in the United Kingdom in 2008 [20]. As of 2015, MBZP has been 
unscheduled in Canada and has no medical use but has been legally available for use as a 
research chemical [20].  
1.1.8 NFLIS Special Report 
The National Forensic Laboratory Information System (NFLIS) issued a special 
report in 2011 on emerging piperazines and how they are becoming more prevalent in 
society [21].  From 2007 to 2009, the number of reports due to piperazines increased to 
about 20,000.  Many of these piperazines were identified as BZP or TFMPP [21].  
Because of their increase in popularity, synthetic piperazines are of increasing interest in 
the forensic laboratory. 
1.2 Liquid Chromatography 
 Liquid Chromatography (LC) is a method of separation that is based on the 
distribution of sample components and their affinity for the solid stationary and liquid 
mobile phases [22]. It has been used in a variety of fields including biology to determine 
DNA base composition [23], in biochemistry to analyze and quantitate amino acids [24] 
and in forensic toxicology coupled with MS to study drugs of abuse, therapeutic drugs 
and poisons [25, 26]. LC has been used more often over gas chromatography methods 
because samples can be run at room temperature and do not need to be thermally stable     
[26]. 
LC can be used in a normal phase or reversed phase. Normal phase LC is where 
the stationary phase is very polar and the mobile phase is very non polar [22]. In this 
phase, since the stationary phase is very polar, the non-polar analytes are eluted off the 
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column first with short retention times as the polar analytes have a much higher affinity 
for the stationary phase. Reversed phase LC includes a relatively non-polar stationary 
phase and a polar mobile phase and typically uses water as the base [22]. As expected, 
the polar analytes elute off the column first and the non-polar analytes take longer as they 
have a higher affinity for the stationary phase. 
1.2.1 Theory 
 Liquid Chromatography (LC) relies on the pumps to pass pressurized liquids that 
contain a sample mixture through a column filled with solid material. Components in the 
sample interact with the phases differently and pass through the column at different rates 
leading to the separation of compounds [27]. The basic components of the LC are solvent 
reservoirs, pumps, injector and the column. The LC is typically coupled with a detector 
and for this project, data from the LC-MS/MS was used. Once detected, a chromatogram 
and mass spectrum of intensity versus time is produced. The intensity, or peak 
height/area, is what was used in this project to calculate the limit of detection. 
1.2.1.1 Mobile Phase and Pumps 
 The mobile phase used in LC are solvents or mixtures of solvents housed in the 
solvent reservoirs [22]. These components need to be high-grade solvents of known 
composition and are not inexpensive. The pumps are connected to the solvents via tubing 
and fitted through a suction line. Most pumps are reciprocating meaning a piston is 
driven back and forth to provide constant flow of solvents and help to control the delivery 
rates of the solvents [22]. 
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1.2.1.2 Injectors 
 Different types of injectors exist, however, the most common injector is a six-port 
loop injector. This injector is a stainless steel body and has six connections for tubing: 
mobile phase, column, waste and sample. This injector can be run in a load mode, which 
allows for the sample to be introduced and communicate with a fixed volume loop and 
then to the waste container. This process allows the loop to be filled at atmospheric 
pressure while keeping the column flow maintained [22]. The injector can also be run in 
inject mode allowing the pump to flush the contents loop into the column to be separated 
and analyzed [22]. Injections can be done automatically or manually by the user. Auto 
injectors allow multiple samples to be run and analyzed without operator interaction. 
1.2.1.3 Column 
 Typically, two LC columns (guard and analytical) exist in tandem in the 
instrument. The guard column is placed between the injector and the analytical column in 
order to protect the analytical column by trapping compounds that may have a very high 
affinity for the packing and could be detrimental to the life of the column [22]. The 
analytical column is where the separation of components occurs based on their affinity 
for the stationary and mobile phase [22]. 
1.3 Mass Spectrometry 
 Mass Spectrometry (MS) is an analytical technique that ionizes chemical species 
and sorts those ions depending on their mass to charge ratio. It is used in many fields and 
can be used for pure samples as well as complex mixtures [28, 29]. MS is used for 
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structural confirmation of organic [30, 31], bioorganic [32, 33] and organometallic 
compounds [34, 35] and for quantitative purposes in forensics [25, 36]. 
1.3.1 Theory 
 The basic components of a MS are the ion source, mass analyzer and detector. A 
schematic of the MS is depicted in Figure 2.  
 
Figure 2. Schematic of Mass Spectrometer. 
 
In general, the sample is injected and the molecules are ionized. Once ionized, these ions 
are separated by mass and charge by a mass analyzer. Once analyzed by the mass 
analyzer, the ions that are targeted are detected and the signal is amplified. 
1.3.1.1 Ionization Techniques 
Soft ionization techniques like matrix-assisted laser desorption/ionization 
(MALDI) and electrospray ionization (ESI) are techniques that have been successfully 
applied to protein and peptide detection and interpretation [37]. Soft ionization results in 
little fragmentation. For example, Ganem et al. described the first successful technique 
for the identification of noncovalent binding of immunosuppressors to a cytoplasmic 
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receptor. [38] They suggested that other macromolecules like acidic proteins or 
oligonucleotides may be detectable under similar ionization conditions [38]. It allows for 
the transfer of non-covalently bound complexes into a gas phase [37]. MALDI permits 
the analysis of high-molecular-weight compounds with high sensitivity [39] and is a 
method that allows for the ionization and transfer of a sample from a condensed phase to 
the gas phase. ESI is used to produce gaseous ionized molecules from a liquid solution by 
creating a fine spray of highly charged droplets in the presence of a strong electric field 
[39]. While ESI has been used extensively in biological research, specifically in the use 
of lipid analysis [40], it, along with MALDI, is of common use in the forensic community 
[41]. Other soft ionization techniques include fast atom bombardment (FAB), chemical 
ionizations (CI) and atmospheric-pressure chemical ionization (APCI). Developed by 
Michael Barber [42], FAB uses high energy atoms which strike a surface and create ions 
and produces primarily intact protonated molecules. Developed by Mason, CI uses a 
lower energy process than ESI and yields less or even no fragmentation. This typically 
results in a simpler spectrum [43]. Hard ionization techniques impart high quantities of 
residual energy into subject molecules and invoke large degrees of fragmentation [39]. 
Electron ionization (EI) is the most common, and one of the first commercialized hard 
ionization techniques. As such it plays an important role in the routine analysis of small 
molecules typically below a molecular weight of 600 Daltons [39], which is of 
importance to the forensic community, specifically in the detection and quantification of 
drugs [44, 45]. 
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1.3.1.2 Mass Analyzers 
Instruments have variations in their capabilities and are designed for an intended 
purpose. Specifically, mass analyzers are designed to contribute to accuracy, range, and 
sensitivity [39]. Six types of mass analyzers exist (quadrupole, magnetic sector, time-of-
flight (TOF), quadrupole ion traps, and Fourier transform-ion cyclotron resonance (FT-
ICR) and each has advantages and disadvantages [39]. Quadrupole analyzers are typically 
used in conjunction with EI sources and have been since the 1950s. [39, 46]. Quadrupoles 
have four parallel metal rods that are each connected electrically. Ions travel between the 
rods, however only ions with a certain m/z ratio will reach the detector while other ions 
will collide with the rods [47]. Quadrupoles are of use in forensics as well as other fields 
because they are capable of routinely analyzing up to an m/z of 3000, which is the 
upwards value for many ionized proteins or other biomolecules [39]. TOF is one of the 
simplest mass analyzers and is commonly coupled with MALDI ionization [39]. TOF 
consists of a path of a certain length and determines the amount of time it takes for an ion 
to reach the detector. Smaller ions reach the detector faster than larger ions. Not only has 
TOF mass spectrometry been used in the forensic community [48, 49], infectious diseases 
in humans have also been detected and analyzed using MALDI/TOF mass spectrometry 
[50, 51] among others. Other mass analyzers are available but are not of common use in 
forensics. They have been used more commonly in physics [52] and in geology to 
observe fragmented ions of radioactive elements like uranium and thorium [53]. 
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1.3.1.3 Ion Detectors 
Common ion detectors include the faraday cup, electron multiplier and 
photomultiplier conversion dynode. The electron multiplier is the most common means of 
detecting ions and achieves high sensitivity by extending the principle used with a 
Faraday cup [39]. Ions strike the dynode surface and electrons are emitted. This process 
is repeated for the multiple dynodes present in the electron multiplier at increasing 
potentials. In the end, this results in a cascade of electrons to be analyzed [39]. Software 
analyzes the signals and the output is a trace of m/z on the abscissa and the signal 
intensity, typically related to the abundance or number of molecules, is the ordinate [54]. 
1.4 Linear Dynamic Range 
 The dynamic range is defined, according to Skoog and colleagues, as the range of 
concentrations at which signal response is linear [55]. Thus, the dynamic range is the 
useful linear quantitative range of an analytical method. Though Skoog et al described the 
dynamic range in terms of a linear model, others have suggested non-linear models to 
quantify analytes of interest can be used [56-59]. Despite the alternatives, the use of 
linear models is commonly found through the analytical literature due to its ease of 
application [60-63]. As such, for purposes of this work, the linear dynamic range and 
therefore LOD will be the area of focus. A graphical representation of the dynamic range 
is shown in Figure 2. 
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Figure 3.  Linear Dynamic range of an analytical method. LOQ=Limit of quantitation; LOL=limit of 
linear response 
 
Figure 3 depicts the linear dynamic range of an analytical method taking into account the 
limit of quantitation (LOQ) and limit of linearity (LOL). The dynamic range can be 
obtained from a calibration curve derived from a series of standards containing the 
analyte of interest at well-characterized concentrations. Typically, as concentration of an 
analyte increases, the instrumental response also increases in a linear fashion up to a 
point. This point is the limit of linear response (LOL) and is the concentration at which 
the curve begins to plateau or change shape. Characterizing the dynamic range is of 
importance since it defines the working concentration range for analytical applications. A 
well-characterized linear dynamic range that is spread over a large concentration range 
can lead to the development of a sensitive, robust and simple analytical method. For 
example, well-defined dynamic ranges for quantification of small molecules and targeted 
peptides resulted in a simple process to quantify multiple small molecules [64]. Another 
example can be found in the work of Thakur et al, who determined the use of a linear 
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dynamic range allows for faster results and simpler LC-MS/MS methods for 
quantification during drug research [64]. 
1.4 Limit of Detection and Sensitivity 
 The limit of detection (LOD) is the minimum amount of analyte (concentration, 
mass, number of molecules, etc.) that can be given a pre-determined confidence level 
[55]. In general, for the analyte-based signal to be quantified with certainty, it must be 
significantly larger than noise. Thus, the signal threshold, 𝑆𝑇, is set by evaluating the 
probability that the measured signal, ?̂?, exceeds 𝑆𝑇 in the absence of analyte as per 
    𝑃𝑟(?̂? > 𝑆𝑇|𝑁 = 0) <∝    (1) 
where ?̂? is the measured signal, 𝑆𝑇 is the signal threshold and N is the number of analyte 
molecules. Thus, ∝ is the risk of falsely labeling noise as analyte signal and is the Type I 
error. Early discussions of the subject were published by Kaiser [65], in which he argued 
that a reasonable ∝-limit for analytical purposes is 0.0013. Practically speaking, to obtain 
this value one would run a number, e.g. 30, of blanks using the process that would be 
applied to the unknown sample. The signal would be analyzed and the mean and standard 
deviation of the noise signal computed. If normally distributed then the 𝑆𝑇 is 
     𝑆𝑇 = 𝜇𝑁 + 𝑘𝑑𝑁    (2) 
where 𝑆𝑇 is the signal threshold, 𝜇𝑁 is the mean noise signal, k is the factor chosen based 
on the Type I line of risk and 𝑑𝑁 is the standard deviation of noise. Thus, if k=3, 𝑆𝑇 
would afford reasonable certainty that noise will not exceed signal, 𝑆𝑇. If 𝑆𝑇 and the 
linear relationship between concentration and signal is known such that c, the calibration 
sensitivity is well characterized as per 
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     𝑆𝑐 = 𝑐𝑁     (3) 
where 𝑆𝑐  is the signal obtained when N molecules are evaluated then 
𝑆𝑐
𝑁
 = c (assuming no 
instrument bias), then 𝑆𝑐 = 𝑆𝑇 at N=0 such that ∝<0.0013 and 
     𝐿𝑂𝐷 =
𝑆𝑇
𝑐
     (4) 
Diagrammatically, this is depicted in Figure 4. 
 
Figure 4. Schematic of Limit of Detection. 
Ultimately, the risk assessment or the  one can tolerate is dependent upon the 
applications, though ’s of 0.03 or 0.0013 are regularly used in the analytical literature 
[54]. It is of note that the above discussion assumes normality in distribution. In many 
cases, however, simple classifications of normality are unfounded and in such cases, a 
log-normal [66] or gamma [67] distribution-classifications may be appropriate. 
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 In further areas of discussion, Figure 4 shows that c cannot be known. Rather, 
there is a confidence interval which encapsulates the expectation. As such, if  
𝑆𝑇
𝑐
 is used 
to appropriate LOD, then the error in c is assumed to be 0, or, in other words, c is taken 
as ground truth. Discussions as to the limits of this are available in the literature [54]. In 
particular, Winefordner et al., provide a mechanism by which the confidence limit may 
be utilized to determine an LOD which accounts for all uncertainty. This is graphically 
depicted in Figure 4 as LOD2. Since LOD2 takes into account all uncertainty, it is, in 
general larger than LOD1 and may be viewed as a conservative rule for LOD. 
 Thus, in general, and in the forensic context, an instrument-analyte couple would 
be considered viable if the LOD was sufficiently low. A low LOD connotes a powerful 
process by which to determine presence of analyte. If ?̂? < 𝑆𝑇 is obstained, then it does 
not suggest that the analyte is absent; rather it suggests that the signal is indiscernible 
from noise. 
 For forensic applications, low LODs are of importance because in many cases the 
sample is subjected to environmental assaults which may compromise the structure, and 
thus, the ability to detect. Though LOD is not the only figure that suggests an analytical 
technique is of value for a given application, it is an important one and, thus, will be the 
focus of the study described herein. 
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2. MATERIALS AND METHODS 
2.1 Calibration Curve Validation 
Data from the Liquid Chromatography-tandem Mass Spectrometer (LC-MS/MS) 
was previously generated and consisted of signal intensity information in the form of 
peak height and peak area, from titrations of eight synthetic piperazines. The area ratio 
between internal standard and analyte was calculated by dividing the area signal from the 
analyte by the corresponding area signal from a deuterated internal standard (BZP-d7, 
TFMPP-d4, mCPP-d8). Area ratio versus concentration was plotted for eight analytes 
(BZP, FBZP, MBZP, MeOPP, mCPP, TFMPP, pFPP and DCPP) to obtain a replica of 
the calibration curve obtained by Raquel LeBlanc [5]. Ordinary least squares (OLS) 
regression was performed for each of the analytes and the slope and R-squared values 
were compared to values from [5]. 
2.2 Number of Molecules 
In many instances the LOD is expressed as a concentration; however, by simple 
conversion it may also be expressed as the absolute number of molecules that can 
confidently be detected given specified laboratory parameters. For purposes of this work, 
the concentration, C, was converted to N, or the number of molecules, by equation 5: 
   𝑁 =  
𝐶∗𝐼∗𝐴
𝑀𝑊
    (5) 
Here, C is the concentration of the analyte in ng/mL and ranged from 20 ng/mL to 
2000 ng/mL. I is the injection volume in mL of the analyte that was injected into the LC-
MS/MS and is equal to .005mL [5]. A is Avogadro’s number and is 6.022x1023 and MW 
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is the molecular weight of the analytes-of-interest. The molecular weights of each analyte 
is shown in Table 1. 
Table 1.  Molecular weight of each analyte.  Molecular weight was calculated by adding up the weight of 
each atom present in the molecule. 
ANALYTE 
MOLECULAR WEIGHT 
(G/MOL) 
BZP 
176.258 
FBZP 
195.256 
MBZP 
190.294 
MEOPP 
192.258 
PFPP 
180.222 
MCPP 
196.676 
TFMPP 
230.230 
DCPP 
231.120 
 
2.3 Area Signal/Ratio versus Number of Molecules Graphs 
The peak area signal versus number of molecules was plotted. Ordinary Least 
Squares (OLS) analysis was performed for the area signal three separate times to include 
n=6, 5 and 4 concentration points. These graphs were later used to determine the linear 
dynamic range for downstream analysis. 
2.4 T-test for Correlation 
A t-test for correlation was performed on the area ratio versus number of 
molecules graph using [68]: 
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     𝑡𝑐𝑎𝑙𝑐 =
|𝑟|∗√𝑛−2
√1−𝑟2
    (6) 
 R-squared is the correlation coefficient for the data and was obtained from the 
linear regression analysis and n is the number of data points used. The t-test was 
performed using n=6, 5 and 4 for all analytes. The t-value for comparison was obtained 
from a standard t-table for a 95% confidence level using n-2 degrees of freedom [68]. 
2.5 Limit of Detection Calculation 
 The propagation of errors approach demonstrated by Long and Winefordner was 
used to evaluate LOD2 which is the limit of detection in number of molecules as opposed 
to concentration [54]. The error in both the y-intercept (b) as well as the slope (m) was 
taken into account as detailed in Section 1.4. Equation 7 is the general format for a line 
and was used for the error propagation to calculate LOD2. 
     𝑦 = 𝑚𝑥 + 𝑏     (7) 
Equation 3 was rearranged to solve for x and is given in equation 4:   
     𝑥 =
𝑦−𝑏
𝑚
      (8) 
Since equation 4 utilizes subtraction and division, the errors in it can be determined using 
the theory of propagation of errors (Eq. 9). 
    𝑠𝑥
2 = (
𝜕𝑥
𝜕𝑦
)2𝑠𝑦
2 + (
𝜕𝑥
𝜕𝑏
)2𝑠𝑏
2 + (
𝜕𝑥
𝜕𝑚
)2𝑠𝑚
2    (9) 
      
𝜕𝑥
𝜕𝑦
=
1
𝑚
     (10) 
      
𝜕𝑥
𝜕𝑏
=
1
𝑚
     (11)  
      
𝜕𝑥
𝜕𝑚
=
−(𝑦−𝑏)
𝑚2
    (12) 
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sy, sb and sm represent the standard error in the blank signal, y-intercept and slope, 
respectively. There was no signal produced by the blank so sy is equal to 0 in this 
application. Substituting the derivatives in equation 10, 11 and 12 into equation 9 and 13 
in for sy gives: 
    𝑠𝑥
2 = (
1
𝑚
)
2
𝑠𝑏
2 + (−
𝑦−𝑏
𝑚2
)
2
𝑠𝑚
2     (13) 
Simplifying and solving for sx gives: 
     𝑠𝑥 =
√𝑠𝑏
2+(−
𝑦−𝑏
𝑚
)
2
𝑠𝑚
2
𝑚
    (14) 
Equation 14 was compared to Long and Winefordner’s derivation to confirm correctness 
noting the differences in variables used [54]. The limit of detection, LOD2, was 
determined using k*sx where k=3 which designates a 99.87% confidence level. The final 
limit of detection is, thus, given by: 
     𝐿𝑂𝐷2 =
𝑘√𝑠𝑏
2+(−
𝑦−𝑏
𝑚
)
2
𝑠𝑚
2
𝑚
   (15) 
Using equation 15, the limit of detection for each of the eight analytes was calculated 
using the slope and intercept values obtained from the linear regression of area signal 
versus number of molecules. 
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3. RESULTS AND DISCUSSION  
3.1 Calibration Curve Validation 
The calibration curve contains all eight analytes. All curves were graphed as a 
linear regression of concentration versus peak area ratio (the ratio between the most 
intense ion area signal and the corresponding peak area of the deuterated internal 
standard). The analytes and their corresponding internal standards is shown in Table 2.  
Table 2. Deuterated internal standards used to quantitate the eight different analytes. 
INTERNAL STANDARD ANALYTES 
BZP-D7 BZP, FBZP, MBZP 
MCPP-D8 MeOPP, pFPP, mCPP, DCPP 
TFMPP-D4 TFMPP 
 
Using table 2, the peak area ratio was calculated for each concentration. This is shown in 
Table 3. 
Table 3. Peak area ratio for each analyte at each concentration (20ng/mL to 2000ng/mL). 
Analyte 20ng/mL 50ng/mL 100ng/mL 500ng/mL 1000ng/mL 2000ng/mL 
BZP 0.155 0.178 0.680 1.901 3.846 7.050 
FBZP 0.073 0.170 0.670 1.814 3.829 6.541 
MBZP 0.139 0.416 1.153 4.412 9.314 16.707 
MeOPP 0.067 0.163 0.593 1.454 3.343 6.333 
pFPP 0.227 0.510 1.491 3.516 7.420 13.729 
mCPP 0.116 0.260 0.755 1.831 3.752 7.252 
DCPP 0.054 0.123 0.462 1.275 2.296 4.613 
TFMPP 0.299 0.630 1.624 3.691 7.168 13.457 
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Upon graphing the peak area ratios from Table 2 versus concentration for each analyte, 
linear regression analysis was performed and R2 and slope values were obtained for each 
analyte. These values were compared to the results in [5]. As the concentration of the 
analyte increased, the peak area ratio also increased in a linear fashion. All R2 and slope 
values are consistent with the results in [5]. The results are summarized in Table 4.   
Table 4: R2 and slope values for Area Ratio versus Concentration. 
ANALYTE R2 
[5] | THIS WORK  
SLOPE 
[5] | THIS WORK  
BZP 0.999| 0.997 0.003 | 0.003 
FBZP 0.999 | 0.993 0.004 | 0.003 
MBZP 0.998 | 0.995 0.006 | 0.009 
MEOPP 0.999 | 0.998 0.003 | 0.003 
PFPP 0.998 | 0.999 0.005 | 0.007 
MCPP 0.999 | 0.999 0.004 | 0.004 
DCPP 0.999 | 0.999 0.003 | 0.002 
TFMPP 0.999 | 0.999 0.007 | 0.007 
Table 4 demonstrates that small, but real, differences between the R2 and m values exist 
and is the result of the differences in the lease-squares methodologies between the study 
whereby [5] utilized a weighted least-squares regression (WLS) and here an OLS 
regression was applied. In general, for analytical purposes the WLS regression is often 
applied since the OLS assumes that the standard errors remain constant throughout the 
concentration range. In many applications, this assumption has been shown to be an 
oversimplifications and therefore WLS may be an appropriate method, in general; 
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however, given the consistency between the two techniques the OLS regression was  
applied in this work.  
3.2 Number of Molecules 
The number of molecules for each analyte at each concentration was calculated  
using equation 1 and the molecular weights from Table 1. These values are shown in  
Table 5. It is important to determine these values in order to calculate the limit of  
detection on an absolute scale. Long and Wineforder among others define the limit of  
detection as a number typically expressed in concentration that describes the lowest  
concentration level of an analyte that is detectable and significantly distinguishable from  
an analytical blank [54, 68-70]. Since concentration and the number of molecules are  
directly related, the latter value was obtained and used to determine a limit of detection  
for the eight analytes of interest in this study. 
Table 5: Number of molecules for all analytes.  Value was calculated from equation 1 and 
information from table 1 for each concentration 
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however, given the consistency between the two techniques the OLS regression was 
appli d in this w rk.  
3.2 Number of Molecules 
 The number of molecules for each analyte at each concentration was calculated 
using equation 1 and the molecular weights from Table 1. These values are shown in 
Table 5. It is important to determine these values in order to calculate the limit of 
detection on an absolute scale. Long and Wineforder among others define the limit of 
detection as a number typically expressed in concentration that describes the lowest 
concentration level of an analyte that is detectable and significantly distinguishable from 
an analytical blank [54, 68-70]. Since co centration and the number of molecules ar  
directly related, the latter value was obtained and used to determine a limit of detection 
for the eight analytes of interest in this study. 
Table 5: Number of molecules for all analytes. Value was calculated from equation 1 and information 
from table 1 for each concentration 
ANALYTE 20NG/ML 50NG/ML 100NG/ML 500NG/ML 1000NG/ML 2000NG/ML 
BZP 3.417E+11 
 
8.541E+11 
 
3.417E+12 
 
8.541E+12 
 
1.708E+13 
 
3.417E+13 
 
FBZP 3.084E+11 
 
7.710E+11 
 
3.084E+12 
 
7.710E+12 
 
1.542E+13 
 
3.084E+13 
 
MBZP 3.165E+11 
 
7.911E+11 
 
3.165E+12 
 
7.911E+12 
 
1.582E+13 
 
3.165E+13 
 
MEOPP 3.132E+11 
 
7.830E+11 
 
3.132E+12 
 
7.831E+12 
 
1.566E+13 
 
3.132E+13 
 
PFPP 3.341E+11 
 
8.354E+11 
 
3.341E+12 
 
8.354E+12 
 
1.671E+13 
 
3.341E+13 
 
MCPP 3.062E+11 
 
7.655E+11 
 
3.062E+12 
 
7.655E+12 
 
1.531E+13 
 
3.062E+13 
 
DCPP 2.606E+11 
 
6.514E+11 
 
2.606E+12 
 
6.514E+12 
 
1.303E+13 
 
2.606E+13 
 
TFMPP 2.616E+11 
 
6.539E+11 
 
2.616E+12 
 
6.539E+12 
 
1.308E+13 
 
2.616E+13 
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3.2.1 Peak Height or Peak Area 
Peak height and peak area are both used for quantitation purposes in a forensic 
laboratory. An article published by Chrom Academy discussed the differences between 
using the peak height versus the peak area in quantitative analysis when using High 
Performance Liquid Chromatography (HPLC) [71]. Most of the time, peak height and 
peak area achieve the same results, however, peak area can be useful when using HPLC 
because the peaks may be tailed and area values are more repeatable while height values 
will fluctuate [71]. O’Haver showed the peak height signal is lower and has a greater 
width while the area under the curve is almost exactly the same as that of a sample 
without dilution [72]. Because of this, this study moved forward using peak area as 
opposed to peak heights.  
3.2.2 Absolute Signal and Area Ratio Signal 
 The absolute peak area signals for all concentration levels as well as the peak area 
ratio (the ratio between the signal of the analyte and the signal of the internal standard) 
were both analyzed in this study. Area signal and area ratio were graphed versus the 
number of molecules to see if a trend existed and can be seen in Figure 5. 
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Figure 5. Area Signal (primary) and Area Ratio (secondary) versus number of molecules. As the 
number of molecules for each analyte increase, the area signal (black) and area ratio (orange) both increase 
in a linear fashion. a: BZP, b: mCPP, c: DCPP, d: FBZP, e: MeOPP, f: MBZP, g: pFPP, h: TFMPP. 
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Figure 5 is a plot of area signal on the primary vertical axis and area ratio (peak area of 
analyte divided by peak area of corresponding internal standard) on the secondary 
vertical axis versus the number of molecules for each of the eight analytes. All eight 
graphs demonstrate a linear relationship between area signal (black) and number of 
molecules as well as between area ratio (orange) and number of molecules. In a study by 
Shenberg and Amiel, they did an experiment to study the variation and analytical 
significance of peak intensities and peak ratios with X-ray fluorescence spectroscopy 
[73]. In their study, they looked at X-ray peaks that were detected of uranium in solutions 
as well as the proportion to uranium over a wide range of concentrations [73]. In Figure 
5, whether looking at the area signal or the area ratio, all eight analytes seem to exhibit 
the same behavior of a plateau after the fourth concentration point (500ng/mL) and 
therefore, it was not significant enough to only use the ratio calculations. This conclusion 
is consistent with Shenberg and Amiel as they found using the ratio only allowed them to 
ignore the exact sample thickness in their x-ray study and did not have significant 
differences between the two methods [73].   
 Skoog and colleagues discuss how the use of an internal standard tends to reduce 
uncertainties arising in sample preparation and introduction of the sample into the 
instrument [55]. The use of internal standards warrants the use of peak area ratios instead 
of the absolute area signal without taking the internal standard into account. However, to 
compute the LOD on an absolute scale, the absolute peak height, rather than the ratio is 
easily applied.  
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The area signal was plotted against N. However, to confirm that the absolute areas 
can be used without detrimentally impacting downstream calculations, the peak area of 
the internal standard was plotted against the N to confirm that detection effects are not 
induced by saturation or other sources. Figure 6 shows internal standard signal versus the 
number of molecules, N. In each case the corresponding peak area of the internal 
standard, in general, maintains a consistent signal intensity throughout the range, 
suggesting minimal concentration effects. Of note is, however, the tendency of the last 
two points to be less than the forth. This trend was observed for all analytes; thus, careful 
consideration as to the concentration range, or linear dynamic range, that ought to be 
utilized for purposes of determining LOD2 is warranted. 
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Figure 6. Internal standard signal versus corresponding analyte number of molecules. The three 
analytes used with BZP-d7 (c, e, h) show a random relationship between the internal standard signal and 
the number of molecules while the four used with mCPP-d8 (b, d, f, g) and the one used with TFMPP-d4 
(1) show a plateau after the fourth concentration point (500ng/mL).  
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 To do this, graphs of the area signal versus the number of molecules were made 
and a T-test for Correlation was performed for all data sets six (n=6), lowest five (n=5) 
and lowest four (n=4) concentrations. 
 
 A null hypothesis that there is no correlation between the area and height signal 
and the number of molecules was used. Using the process described in Chapter 5 of [68], 
a t-value was calculated for all analytes using the lowest six, five and four concentration 
points [68]. Table 6 shows the results for the t-test calculation (tcalc) using equation 6 and 
=0.05 for all analytes using n=6, 5 and 4 using critical t-values (tcrit) from [68]. 
Table 6: Results of the t-test calculation from Equation 2. All t-test results obtained show a significant 
correlation between peak area ratio and the number of molecules. 
ANALYTE PFPP MBZP MEOPP FBZP DCPP MCPP BZP TFMPP 
n=6, 
tcrit=2.78 
11.48 15.06 12.84 14.79 12.72 13.28 14.43 11.78 
n=5, 
tcrit=3.18 
34.32 6.31 32.63 6.60 13.70 28.62 5.89 17.97 
n=4, 
tcrit=4.30 
13.59 7.02 13.76 11.82 10.40 12.55 8.90 11.02 
 
All tcalc values are above the tcrit and therefore the null hypothesis of zero correlation is 
rejected. With these results, it was determined that all six, five or four concentrations 
could be used for analysis.  
3.3 Limit of Detection 
 As defined by the International Union of Pure and Applied Chemistry (IUPAC) 
and described in [54], the limit of detection is the smallest measure that can be detected 
with reasonable certainty for a given analytical procedure [54]. The limit of detection 
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(LOD2) was calculated for each analyte when using all six concentration points and four 
concentration points. Table 7 shows the results for LOD2 for each analyte. 
Table 7: Limit of detection. LOD was calculated with above equations at the full dynamic range as well as 
with only four concentration points. Each value represents the number of molecules detected at the limit of 
detection. 
ANALYTE N=6 N=4 
TFMPP 3.15E+12 9.63E+11 
PFPP 4.12E+12 9.98E+11 
MBZP 2.96E+12 1.85E+12 
MEOPP 3.44E+12 9.26E+11 
FBZP 2.94E+12 1.06E+12 
DCPP 2.89E+12 1.02E+12 
MCPP 3.26E+12 9.91E+11 
BZP 3.34E+12 1.56E+12 
 
 
The limit of detection when using all six concentration points does not produce a large 
difference from those when using the lowest four concentration points however using n=4 
resulted in lower LOD2’s. Currie demonstrated in his work that if the standard deviation 
in the region between zero and the LOD is reasonably well known, then it is preferable to 
use data closer to the origin [69]. The limit of detection calculated with four 
concentration points correlates more closely to the LOD’s obtained in [5] than all six 
concentrations which correlated with the LOQ and was the lowest concentration that 
could be quantified within +/- 20% accuracy as defined by SWGTOX guidelines for 
method validation [74]. The study described in [5] used a calibration model to determine 
these values. Concentrations of synthetic piperazines were prepared in both blood and 
urine using a range of concentration from 1 to 2000 ng/mL. Upon preparation with solid 
phase extraction, reconstitution and running on the LC-MS/MS five times [5] determined 
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the LOD to be 10 ng/mL for mCPP (𝑁 = 1.531𝑥1011) and TFMPP (𝑁 = 1.308𝑥1011)  
and 20 ng/mL for all other analytes (𝑁𝑝𝐹𝑃𝑃 = 3.341𝑥10
11, 𝑁𝑀𝐵𝑍𝑃 =
3.165𝑥1011, 𝑁𝑀𝑒𝑂𝑃𝑃 = 3.132𝑥10
11, 𝑁𝐹𝐵𝑍𝑃 = 3.084𝑥10
11, 𝑁𝐷𝐶𝑃𝑃 =
2.606𝑥1011, 𝑁𝐵𝑍𝑃 = 3.417𝑥10
11) [5]. The author of [5] computed the LOD by 
evaluating the lowest signal at which the computed concentration was 20% of the known 
concentration. Interestingly, despite the differences in method, the LOD’s were 
consistent, suggesting the LC-MS/MS methodology is powerful at detection low 
concentrations of analyte. 
Traditionally, the limit of detection is calculated using signals from the blank and 
Skoog and colleagues have given the limit of detection by [55] 
     𝑐𝑚 =
𝑆𝑚−𝑆̅𝑏𝑙
𝑚
     (13) 
Sm is the minimum distinguishable analytical signal, Sbl is the mean blank signal and m is 
the slope of the straight line. Interestingly, those common, traditional means of 
determining LOD were not applicable since the high specificity of LC-MS/MS resulted in 
no detectable signal from the blanks. That is, noise measurements were not available; 
therefore, 𝑆𝑏𝑙̅̅ ̅̅  and 𝑆𝑚 could not be determined. Methods to determine LOD from blanks 
are described elsewhere [65, 68]. However, the work summarized herein demonstrates 
that the LOD can successfully be extrapolated using the method of Long and 
Winefordner, which was the theory of propagation of errors [54]. Therefore, in cases 
where blank signal is not available this work shows that having multiple means of 
determining LOD is useful. 
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4. CONCLUSIONS 
4.1 Summary of Findings 
 As demonstrated in the results of this research, the limit of detection can be 
determined even when signal from blanks or noise signal is unavailable. The limit of 
detection determined herein was consistent with the results of the lowest concentration 
(20ng/mL) chosen for synthetic piperazines during method validation. This value was 
similar whether using all six concentration points or using the lowest four. When only 
using the lowest four concentrations (20ng/mL, 50ng/mL, 200ng/mL, 500ng/mL) the 
calculated LOD was lower than results of the lowest concentration, suggesting that the 
LC-MS/MS method is not only a sensitive and specific method for determining the 
concentration presence of these eight forementioned compounds, but a powerful one as 
well. Though it is common practice and recommended to include an internal standard 
when quantifying analytes of interest, a good and consistent approximation of the LOD 
may be acquired by absolute signal intensities. 
4.2 Significance of Findings 
 Although common, the general approach to calculating the LOD may not be 
applicable in all scenarios. If an analyst does not have a blank signal, then extrapolation 
of the data and error of propagation can be used to determine the LOD for different 
classes of drugs based on data obtained through a validation study may be an alternative. 
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